グロース・キャピタル株式会社 filed a Change Report with the Finance Bureau on 5 November 2026, reporting that its holding in D.Western Therapeutics Institute, Inc. had decreased by 1.06 percentage points to 41.90%. The date on which the reporting obligation arose was 28 October 2026.
グロース・キャピタル株式会社 filed a Change Report on its holding in D.Western Therapeutics Institute, Inc., listed on the TSE Growth Market, under the 5% Rule. The report was filed with the Finance Bureau on 5 November 2026.
According to the report, the holding stood at 41.90%, down 1.06% from the previous report. The decrease was attributed to a change in the breakdown of the securities held.
The date on which the reporting obligation arose was 28 October 2026, and the report covered the holding position as of that date. The filing with the Finance Bureau constituted the public disclosure.
The related links also included the Tokyo Stock Exchange and financial and fiscal news, and developments concerning the reported holding in D.Western Therapeutics Institute, Inc. are attracting attention.